Ligand profile
9L8
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: KP13_00667 — Glycogen phosphorylase
Identifiers
Database identifiers and provenance.
- Ligand ID
9L8- PDB
5o56- UniProt (similar protein)
P00489- Target protein
- KP13_00667
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 137.5
- −1 ≤ LogP ≤ 5 0.11
- MW ≤ 500 Da 356.4
- LogP ≤ 5 0.11
- H-bond donors ≤ 5 5
- H-bond acceptors ≤ 10 7
- Rotatable bonds ≤ 10 3
- TPSA ≤ 140 Ų 137.5
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
c1ccc2cc(ccc2c1)c3nc([nH]n3)[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)Nc1ccc2cc(ccc2c1)c3nc([nH]n3)[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)N
InChI=1S/C18H20N4O4/c19-13-15(25)14(24)12(8-23)26-16(13)18-20-17(21-22-18)11-6-5-9-3-1-2-4-10(9)7-11/h1-7,12-16,23-25H,8,19H2,(H,20,21,22)/t12-,13-,14-,15-,16-/m1/s1InChI=1S/C18H20N4O4/c19-13-15(25)14(24)12(8-23)26-16(13)18-20-17(21-22-18)11-6-5-9-3-1-2-4-10(9)7-11/h1-7,12-16,23-25H,8,19H2,(H,20,21,22)/t12-,13-,14-,15-,16-/m1/s1
IMNCDLXOKIGZHY-OXGONZEZSA-NIMNCDLXOKIGZHY-OXGONZEZSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF00343
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand 9L8 →
- PDB RCSB structure 5o56 →
- UniProt UniProt P00489 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “9L8”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_00667.
PDB 115
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 100
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).